This is not an official government website.
Copyright © 2026 PLEJ LC. All rights reserved.
Prohibits transplant programs and a specified federal transplant board from denying evaluation, listing, transplantation, or related transplant services to a qualified individual solely because of a disability. It requires covered health care providers and transplant hospitals to make reasonable policy modifications, provide auxiliary aids and supports (including supported decision-making and use of a support network) unless doing so would fundamentally alter care or impose undue burden, and relies on individualized medical determinations when a disability has a medically significant impact on transplant candidacy. Protects rights already available under disability nondiscrimination laws, allows complaints to the HHS Office for Civil Rights for expedited review, and preserves state or local laws that give greater protections than this law provides.
The bill substantially expands and clarifies legal protections and access for people with disabilities across the transplant pathway—improving equity and coverage—while imposing meaningful compliance, administrative, and potential clinical‑decision burdens and costs on providers, payers, and government programs.
People with disabilities will no longer be able to be denied or excluded from organ transplants solely because of their disability, increasing equitable access to transplant care nationwide.
Transplant candidates with disabilities will be able to use auxiliary aids, supported decision-making, and reasonable modifications so they can participate in evaluations and decision-making and receive more accessible care.
Medicare and Medicaid beneficiaries (and other transplant recipients) gain clearer recognition that home- and community-based supports and related post‑transplant services (e.g., immunosuppressive medicines, follow-up care) are considered in the transplant process, which can reduce out‑of‑pocket costs and gaps in coverage.
Hospitals, transplant centers, and providers will face increased compliance and operational costs to provide auxiliary aids, reasonable modifications, policy changes, and to support expanded obligations under the Act.
Expanded enforcement (OCR complaints, ADA/Rehab Act parallel suits) and required policy revisions will raise administrative and legal burdens and liability exposure for transplant programs, the governing board, and providers.
Restrictions on using disability-linked prognostic information could limit the board’s flexibility to set allocation criteria and complicate individualized clinical decision‑making, potentially affecting medical outcomes and clinician discretion.
Introduced May 15, 2025 by Ashley Brooke Moody · Last progress May 15, 2025